



























The genome wide association studies (GWAS) were 
introduced to perform exhaustive analyses of genetic 
influence on complex traits. A number of recent 
publications emphasize that the approach did not 
entirely meet the expectations: Although GWAS 
provided important insights in genetics of particular 
disorders [1], it failed to detect a major portion of 
genetic influence on traits of interest [1-5]. In most 
cases genetic variants found in GWAS cannot explain 
heritability estimates calculated for such traits in the 
pre-genomic era. An important conclusion emerged 
from many such studies was that the complex traits are 
typically affected by a large number of common alleles, 
each of little predictive value, with small or statistically 
non-significant effect [1-5]. Recent suggestion to focus 
on the search for rare alleles with significant phenotypic 
effects in small population subgroups [6] requires new 
SNP data with minor allele frequencies (MAF) less than 
1%. (Traditional GWAS deal will MAF >1%). More 
results could be obtained by sequencing selected areas 
of the genome [7,8] 
In this paper we show that the use of extended approach 
to GWAS allows for addressing the issues of lost 
genetic influence on complex traits by analysing 
regularities of joint action of many small-effect-low-sig- 
 













nificance alleles. Using longevity trait as an example we 
show that the results of our analyses bring important 
insights into mechanisms of genetic regulation of this 
trait. In this approach we hypothesized that value of the 
complex trait (life span) depends on number of the 
small-effect “longevity” alleles, contained in individual 
genomes and tested this hypothesis using genome wide 
data on 550K SNPs from the original cohort of the 
Framingham Heart Study (FHS). The results show that 
the joint influence of small-effect alleles on life span is 
both significant and substantial and can be described as 
the “genetic dose – phenotypic response” relationship. 
The existence of such relationship brings a new 
perspective to GWAS of complex traits and can at least 
partly justify sizable efforts and resources that have 
recently been invested in GWAS.  
We evaluated associations between 550,000 SNPs and 
life spans in 1,173 genotyped participants of the 
Framingham Heart Study (FHS) original cohort. After 
performing a standard quality control procedure [9], 
(call rate ≥80%; MAF>1%; HWE > 10
-7) for each SNPs 
we evaluated parameters of the linear regression model 
by considering individuals’ life span as function of SNP 
genotype (categorical variables) using code “0” for 
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minor allele. The SAS program SAS PROC REG (© 
SAS Institute, Inc.) has been used for this purpose. The 
SNPs for which the estimate of the slope parameter was 
positive and had p≤10
-6 were selected as “longevity” 
SNPs. Note that this threshold is larger than 10
-7 used in 
traditional GWAS with correction for multiple 
comparisons in data samples of similar size. This 
procedure resulted in selection of 169 “longevity” SNPs. 
 
To evaluate joint effect of genetic variants on life span, 
we calculated the number of longevity SNPs (from 
selected set of 169 SNPs) contained in the genome of 
each individual in the study and performed regression 
analyses considering lifespan as a linear function of 







































genome. The estimates of both the intercept and the 
slope were positive and highly statistically significant 
(Figure1).  
 
The estimated dependence explained 21% of variance in 
life span. This estimate seems to be reasonable if one 
takes into account that narrow sense heritability in life 
span is estimated at the level about 25% [10]. The 
estimated relationship between life span and the number 
of longevity SNPs shown in Figure 1 is the main result 
of this paper. It shows that in studies of genetic 
determinants of longevity the joint influence of many 
small-effect genetic variants may be substantial. We 
suggest that similar “genetic dose” – “phenotypic 
response” relationship is likely to characterize genetic 
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additional testing. The first is the use of data on all 
genotyped individuals from the original FHS cohort, 
which include first degree relatives from 618 families. 
The second is the fact that the two procedures: (i) 
selection of longevity SNPs and (ii) testing the presence 
of their joint influence on life span used data on the 
same individuals.    To check whether the exclusion of 
relatives from the list of study subjects modifies the 
results of analyses, we randomly selected 618 
individuals, one from each family, identified a set of 
“longevity” SNPs using the procedure described above, 
and estimated dependence of life span on the number of 
selected longevity SNPs in these individuals. To diminish 
the effect of sampling, we repeated this procedure 10 
times. In each such analysis, the estimates of slope and 
intercept were positive and highly statistically significant 
with p≤10





































about joint influence of longevity SNPs on life span does 
not depend on the presence or absence of relatives among 
the study subjects. To take into account variants selected 
in each experiment, we unified sets of longevity SNPs 
selected in each of 10 experiments. This procedure 
resulted in the set with 70 genetic variants. Note that the 
reduction in the number of study subjects (because of 
excluding genetically dependent individuals) increases 
the chances of selecting false positive variants. To 
diminish the number of such variants, we intersected the 
set of 70 SNPs with the set of 169 SNPs, selected earlier 
using data on the entire FHS cohort. This procedure 
resulted in 39 longevity SNPs.  
 
This set of 39 SNPs was then used in regression 
analyses where life span was considered as a linear 
function of the number of longevity SNPs contained in 









































































One can see from this figure that the estimates of both 
the intercept and slope are statistically significant. The 
Figure 3 shows no dependence of life span from the 
number of SNPs taken randomly from the pool of SNPs 
without 39 selected longevity SNPs.  
 
The analyses showed that the estimates of both the 
intercept and slope are highly statistically significant. 
The estimated dependence of life span on genes 
explains 19% of variance in life span, which is close to 
21% estimated earlier. Thus, the presence of relatives in 
the population used for selecting longevity SNPs does 
not affect the conclusion about the presence of “genetic 
dose” – “phenotypic response” relationship. The fact 
that 39 selected SNPs explained almost the same 
percent of life span variance as 169 SNPs selected 
earlier (19% vs 21%) indicates that this set of SNPs 
deserves further analyses. Table 1 shows how selected 
SNPs are related to known genes.  
 
The second aspect mentioned above deals with 
prediction and replication. If the procedures, described 
above, do select longevity variants,  and if  the  detected  
pattern of joint influence of such variants on life span is 
a property of a biological mechanism, then genetic 






























able to predict life spans in other genetically 
independent population of individuals who experienced 
similar environmental and living conditions. To test 
this, we randomly divided all 618 families into two 
groups. Data on individuals from the first 309 families 
plus data on 162 individuals with missing family 
identities were used for selecting SNPs having effect on 
life span. Then for each individual in the second 
(genetically independent) group we identified the 
number of such SNPs contained in person’s genome. 
We estimated parameters of the linear regression model 
considering life span as function of the number of 
longevity variants contained in the genomes of 
individuals from the same (first) group and from the 
second (independent) group of individuals. To replicate 
the result, longevity SNPs selected from data on the 
second population were used for evaluating linear 
“genetic dose” – “life span response” relationship on the 
same population, as well as on the first population of 
individuals genetically independent from the second 
one.  To reduce the sampling effect, the procedure of 
random division of the 618 families into two groups 
with subsequent selection of longevity variants and 
estimating regression coefficients in the “genetic dose – 
phenotypic response” relationship was repeated 10 
times. The results are shown in Table 2. 
Figure 3. The absence of dependence between the numbers of randomly selected 39 genetic
variants contained in individuals’ genome and life span. These genetic variants were randomly



























































































































Closest gene  Gene full name  Gene/protein 
function 
rs2031577 10  4050003  G  INTERGEN
IC 












rs3847687 12  131525053  T  INTRONIC  0  GPR133  G  protein-coupled 
receptor 133 
transmembranic signal 
transduser; activates G 
proteins within cell 
rs4891159 18  74101941  G  INTRONIC  0  ZNF516  zinc finger protein 
516 
the part of 
transcription factors  
rs10445407 17  79261809  A  INTRONIC  0  SLC38A10  solute  carrier 
family 38, member 
10  
amino acid transporter  
rs4745062 9  73784264  C  INTRONIC  0  TRPM3  transient  receptor 
potential channel  
mediates calcium entry 
potentiated by calcium 
store depletion  
rs2024714 20  60212494  C  INTRONIC  0  CDH4  R-cadherin 
(retinal)  
calcium-dependent 
cell-cell adhesion  
rs7315621 12  132085196  G  INTERGEN
IC 
-60412 AC117500.2    
rs16975963 19  38325536  G  NON 
CODING 
GENE 
0 AC016582.2     
rs4732038 7  134250322  C  INTRONIC  0  AKR1B15  aldo-keto 
reductase family 1, 
member B15 
superfamily of  
reductases  that reduce 
aldehydes and ketones 
to alcohols 




NTHL1 nth  endonuclease 
III-like 1 
base excision repair; 
DNA N-glycosylase of 
the endonuclease III 
family 
rs7874142  9  137704782  A  INTRONIC  0  COL5A1  collagen, type V, 
alpha 1 
regulates the assembly 
of heterotypic fibers in 
tissues  



















































































































rs13008689 2  8530256 G  INTERGENIC  -153466  AC011747.3    




expressed in fetal 
tissues 
rs2882281  13  90622455  C  INTERGENIC  -21630  RP11-388D4.1  locus tag for a 
pseudogene 
 




rs9876781 3  48487338  A  NON   
CODING 
GENE 
0 RP11-24C3.2     
rs6568433 6  106829537  C  INTERGENIC  -39044  AL109920.3     
rs9517320 13  99126303  A  INTRONIC 0  STK24  serine/threonine 
kinase 24 














protein that regulates 
gene expression and 
cell fate; highly 
conserved  
rs739401 11  3036324  T  INTRONIC  0  CARS  cysteinyl-tRNA 
synthetase 
catalyzes the 
aminoacylation of a 
tRNA;  




rs3212335  15  27012141  C  INTRONIC  0  GABRB3  GABA  A 
receptor, beta 
ionic channel family 
that serves as the 
receptor for GABA; 
may be associated 
with memory 
rs6915183  6  166706169  G  INTERGENIC  -12999  PRR18  proline rich 18   
rs4721135 7  1912222  G  INTRONIC 0  MAD1L1  MAD1  mitotic 
arrest deficient-
like 1 

















































One can see from this table that the effect of the number 
of selected “longevity” SNPs on life span is significant 
in both groups. These analyses show that developed 
approach has predictive power, and that joint influence 
of longevity SNPs on life span can be replicated in 
populations of genetically independent individuals.  
 
Some recent studies provide arguments that the 
Bonferroni corrections for multiple comparisons, 
traditionally used in GWAS, are too rigid and should be 













































many genetic variants involved in the “genetic dose – 
phenotypic response” relationship would not be selected 
by traditional GWAS methods. We found that relaxing 
the procedure for selecting longevity alleles (the use of 
selection threshold p≤10
-6 instead of p≤10
-7) increases 
the number of selected longevity SNPs having small 
effects and improve the fit of the life span data by the 
“number of longevity SNPs – life span” curve. This 
suggests that taking effect size of alleles into account 
may help reveal additional features of genetic influence 
on complex traits.  
 
rs3106598  13  61678912 G  INTERGENIC  -304909 PCDH20  protocadherin  20 transmembrane 
receptor,  a role in 
specific cell-cell 
connections in the 
brain  
rs1356888  2  50516018  C  INTRONIC  0  NRXN1   cell adhesion in 
nervous system  
 
rs9616906 22  51104680  G  UPSTREAM  -3552 AC000050.2     
rs13053175 22  37613309  T  UPSTREAM -7992  RAC2  ras-related  C3 
botulinum toxin 
substrate 2 
GTPase of the RAS 
superfamily 
regulating  cell 
growth, cytoskelet, 
and the  protein 
kinases activation  
rs5766691 22  47532396  G  INTRONIC 0  TBC1D22A  TBC1  domain 
family 
 
rs13118159 4  1365127 N/A INTRONIC  0  RP11-
1244E8.1 
  
rs7168365 15  53805825  C  DOWNSTREA
M 
-113 WDR72  WD  repeat 
domain 72 
 
rs7493138  14  29021928  C  INTERGENIC  -213122  FOXG1  forkhead box G1  transcription factors 
rs432203 2  70764688  A INTRONIC  0  TGFA  transforming 
growth factor, 
alpha 
competes with EGF 
for binding to the 
EGF receptor 
rs6813479 4  137660383  A  INTERGENIC  -57494  RP11-138I17.1     




























































The possibility of using a straight line for 
approximating “the number of longevity SNPs -- life 
span” relationship indicates the presence of substantial 
additive component of the genetic contribution to 
longevity. It is relevant to note that additive genetic 
effects were the subject of numerous studies in 
quantitative genetics of the pre-genomic era. Many 
genetic calculations (e.g., estimates of narrow sense 
heritability of complex traits) were based on the 
assumption about the additive nature of genetic 













































genome-wide data nowadays allows for evaluating such 
effects directly. Moreover, evaluating the non-additive 
(non-linear) joint genetic influence (epistasis) becomes 
also possible with the use of more sophisticated patterns 
of the “dose – response” relationship.  
 
While the replication of findings became a standard 
requirement in GWAS, the results of our analyses 
suggest that in studying joint effect of many alleles this 
practice needs to be revised. Our analyses show that one 
should not expect that exactly the same sets of genetic 
Table 2. 
 
# N1 N 2 N 1SNP N 2SNP  1 α  
*
1 α   2 α  
*
2 α  
1 661  512  52  8 0.30  0.26  0.14  0.16 
2 689  484  40  9 0.42  0.35  0.21  0.23 
3 627  546  18 43  0.87  0.80  0.28  0.22 
4 677  496  20 25  0.67  0.63  0.56  0.49 
5 680  493  34 16  0.47  0.41  0.33  0.31 
6 630  543  32 22  0.48  0.39  0.46  0.48 
7 631  542  43 15  0.40  0.31  0.22  0.27 
8 658  515  14 39  0.86  0.99  0.33  0.25 
9 647  526  31 18  0.48  0.38  0.38  0.42 
10 672  501 37  10 0.44  0.37  0.24  0.27 
 
The results of 10 experiments in which genetic variants individually affecting life span (longevity SNPs) were selected 












slope  of  the  regression  line  describing  dependence  between  life  span  and  the  number  of  selected  longevity  SNPs 
contained in genomes of individuals from the second (independent) population. The estimates  1 α and 
*
1 α use SNPs 





line  describing  dependence  between  life  span  and  the  number  of  selected  longevity  SNPs  contained  in  genomes  of 
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response” relationship evaluated using data on other 
population. One reason for this may be gene-
environment interaction: difference in populations’ 
exposure to external conditions is likely to produce 
difference in genetic regulation of the trait in these 
populations. Identification of genetic variants 
“sensitive” to specific external signals will open new 
opportunities for studying the role of genetic and non-
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